Cargando…

Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model

The generation of T cells from pluripotent stem cells (PSCs) is attractive for investigating T cell development and validating genome editing strategies in vitro. X-linked severe combined immunodeficiency (X-SCID) is an immune disorder caused by mutations in the IL2RG gene and characterised by the a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alzubi, Jamal, Pallant, Celeste, Mussolino, Claudio, Howe, Steven J., Thrasher, Adrian J., Cathomen, Toni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622068/ https://www.ncbi.nlm.nih.gov/pubmed/28963568 http://dx.doi.org/10.1038/s41598-017-12750-4

Ejemplares similares

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
por: Mussolino, Claudio, et al.
Publicado: (2014)

Genome Editing With TALEN, CRISPR-Cas9 and CRISPR-Cas12a in Combination With AAV6 Homology Donor Restores T Cell Function for XLP
por: Houghton, Benjamin C., et al.
Publicado: (2022)

Automated generation of gene-edited CAR T cells at clinical scale
por: Alzubi, Jamal, et al.
Publicado: (2020)

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model
por: Rahman, Shamim H., et al.
Publicado: (2015)

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
por: Aushev, Magomet, et al.
Publicado: (2017)

Genome Editing of the SNAI1 Gene in Rhabdomyosarcoma: A Novel Model for Studies of Its Role
por: Ulman, Aleksandra, et al.
Publicado: (2020)

A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
por: Mussolino, Claudio, et al.
Publicado: (2011)

Allele-Specific Disruption of a Common STAT3 Autosomal Dominant Allele Is Not Sufficient to Restore Downstream Signaling in Patient-Derived T Cells
por: König, Saskia, et al.
Publicado: (2022)

Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
por: Bloom, Kristie, et al.
Publicado: (2013)

Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors
por: Fang, Yongxing, et al.
Publicado: (2020)

CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
por: Bexte, Tobias, et al.
Publicado: (2022)

High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
por: Papaioannou, Nikoletta Y., et al.
Publicado: (2023)

Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells
por: Mosti, Laura, et al.
Publicado: (2021)

A novel Cas9 fusion protein promotes targeted genome editing with reduced mutational burden in primary human cells
por: Carusillo, Antonio, et al.
Publicado: (2023)

Clinical genome editing to treat sickle cell disease—A brief update
por: Zarghamian, Parinaz, et al.
Publicado: (2023)

TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis
por: Kuhn, Alexandra, et al.
Publicado: (2017)

Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
por: Bloom, Kristie, et al.
Publicado: (2019)

TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting
por: Yanik, Mert, et al.
Publicado: (2013)

Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy
por: Dibas, Ala, et al.
Publicado: (2023)

TALEN mediated gene editing in a mouse model of Fanconi anemia
por: Pino-Barrio, Maria José, et al.
Publicado: (2020)

Precise Epigenome Editing on the Stage: A Novel Approach to Modulate Gene Expression
por: Mussolino, Claudio
Publicado: (2018)

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2014)

Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells
por: Mlambo, Tafadzwa, et al.
Publicado: (2018)

Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
por: Holkers, Maarten, et al.
Publicado: (2013)

Restoration of Progranulin Expression Rescues Cortical Neuron Generation in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia
por: Raitano, Susanna, et al.
Publicado: (2014)

X-linked SCID with a rare mutation
por: Mahdavi, Fatemeh Sadat, et al.
Publicado: (2021)

Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019)

P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
por: Albinger, Nawid, et al.
Publicado: (2023)

Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg(−/−) mice
por: Du, Yaqin, et al.
Publicado: (2018)

Transient restoration of gene rearrangement at multiple T cell receptor loci in gamma-irradiated scid mice
Publicado: (1996)

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
por: Alzubi, Jamal, et al.
Publicado: (2020)

Generation of Functional Neutrophils from a Mouse Model of X-Linked Chronic Granulomatous Disorder Using Induced Pluripotent Stem Cells
por: Mukherjee, Sayandip, et al.
Publicado: (2011)

Production and rearing of germ-free X-SCID pigs
por: Hara, Hiromasa, et al.
Publicado: (2017)

Correction to: Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg(−/−) mice
por: Du, Yaqin, et al.
Publicado: (2018)

Intact B-Cell Signaling and Function With Host B-Cells 47 Years After Transplantation for X-SCID
por: Deal, Christin, et al.
Publicado: (2020)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019)

Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells
por: Pavel-Dinu, Mara, et al.
Publicado: (2019)

Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs
por: Iancu, Ortal, et al.
Publicado: (2022)

Gene Editing for the Treatment of Primary Immunodeficiency Diseases
por: Rai, Rajeev, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jnrplspdqjaemnj16dudug00qc